Skip to content
CRN NWL Intranet

CRN NWL Intranet

  • Research
    • Research Events
      • North West London Clinical Research Awards
        • Programme
        • Nominees
    • COVID-19 Research Resources
      • COVID-19 Studies Open in NWL
        • Interventional Studies
          • 5773 Safety and Antiviral Activity of Remdesivir for severe COVID-19
          • 5774 Safety & Antiviral Activity of Remdesivir for moderate COVID-19
          • A study to evaluate TCZ in patients with severe COVID-19 Pneumonia
          • COVID-19: ISARIC – Coronavirus Clinical Characterisation Consortium (ISARIC-4C) / CCP-UK
          • COPCOV Trial
          • DeVENT
          • PRINCIPLE
          • RECOVERY
          • RECOVERY-Supportive Care
        • Observational Studies
          • Coronavirus infection in immunosuppressed children
          • DIAMONDS SEARCH v1
          • GenOMICC
          • MERMAIDS – ARI
          • UKOSS: Pandemic Influenza in Pregnancy
      • COVID-19 Recruitment
      • NWL COVID-19 Studies Tracker
      • National and Local Updates
      • Local Reporting
      • Links and Resources
      • Industry
    • Patient Research Experience Survey 2020/21
  • About Us
    • What we do
    • Our Mission, Vision and Values
    • Who’s Who at the CRN
      • Senior Management Team
      • Business Intelligence
      • Research Facilitation
      • Research Delivery
      • Cross-Cutting Themes
      • Strategic Workforce
  • Teams
    • Business Intelligence
    • Communications
      • NIHR and CRN Identity
    • Patient and Public Involvement
    • Continuous Improvement
    • Strategic Workforce
  • Learning & Development
    • Courses
      • People Management Programme: September 2019-January 2020
    • Learning Culture
    • Research Skills Training
    • Your Learning Style
    • Research Mentor & Coach Directory
    • Resources
  • Wellbeing
    • Vision
    • Wellbeing Champions
    • Wellbeing Resources
    • Tri-Network Coaching
    • CONTACT Counselling Service
    • COVID-19 Staff Resources
      • Working from Home
        • Activities for Children
      • Courses and Resources
      • Wellbeing
      • Key Worker Offers
  • Quick Links
    • Getting About

Interventional Studies

  • 5773 – Safety and Antiviral Activity of Remdesivir for severe COVID-19
  • 5774 – Safety & Antiviral Activity of Remdesivir for moderate COVID-19
  • CATALYST – An Early Phase Platform Trial in COVID-19
  • COPCOV – Chloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study
  • COVAC – Clinical trial of a SARS-CoV-2 vaccine in healthy men and women
  • COVACTA – A study to evaluate TCZ in patients with severe COVID-19 Pneumonia
  • CCP-UK – Clinical Characterisation Protocol for Severe Emerging Infection
  • COV001 – A phase I/II trial of a candidate COVID-19 vaccine
  • COV002 – Investigating a Vaccine Against COVID-19
  • DeVENT – Decision support system to evaluate VENTilation in ARDS
  • PRINCIPLE – Platform Randomised trial of INterventions against COVID-19 In older peoPLE
  • RECOVERY – Randomised Evaluation of COVID-19 Therapy
  • RECOVERY-Supportive Care – Ventilation Strategies in COVID-19; CPAP, High-flow, and standard care
  • REMAP-CAP – Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia
  • RUX-COVID – Study to assess the efficacy and safety of ruxolitinib in patients with COVID-19 associated cytokine storm.

Accessibility Statement

https://crnnwl.com/accessibility-statement/

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy